By
AmyT on
March 22, 2010
Many of you may know that the FDA held a two-day Public Hearing on the issue of Glucose Meter Accuracy late last week. Dozens of experts gathered at the Washington DC Hilton/Gaithersburg Hotel to lend testimony.
The issue at hand, according to FDA statements, is that:
“Glucose meters are increasingly being used to achieve tight glycemic control despite the fact that these devices have not been approved for this use. There is currently no consensus…
Read more »
By
AmyT on
November 12, 2009
The Diabetes Technology Society held its annual meeting last Thursday through Saturday, which always takes place just about a mile and a half from my house. But guess what? This was the very first year that I found myself on the inside of this exclusive event, participating in a panel (the very last panel of the 3-day event) on “technologies to drive patient adherence.”
The term “adherence” made me bristle, too, because it sounds like…
Read more »
The New York Times reports today that the rise in the use of home glucose monitors, also in hospitals, is pushing the Food and Drug Administration toward a possible crack-down on accuracy standards. Some of you might say it’s about time, considering that current standards allow a margin for error of up to 20%, which can make a huge difference in the choices we make on food, exercise, and in particular insulin doses.
And who…
Read more »
By
AmyT on
January 19, 2009
Diabetes and heart risk. My goodness do we hear a lot about that. And for good reason: people with diabetes are 2-4 times more likely to develop atherosclerosis (hardening of the blood vessels) and five times more likely to have a stroke than people without diabetes, according to the ADA. Yipes! And then there’s the uproar of late about diabetes drugs that possibly increase the risk of heart attack (although the evidence on Avandia apparently…
Read more »
